services
- Unlicensed Medicines
- ULT Transport
- Biorepository Solutions
- Patient Support Program
- Managed Access Program
- Post-Trial Access
- Early Access Program
- Clinical Trial Comparator Sourcing
- Clinical And Commercial Secondary Packaging And Labeling
- Clinical trials logistics
- Clinical Trial Material Storage and Distribution
- Global Logistics for Life Sciences
- Pharmaceutical wholesale distribution
- Specialty Medicines
- Regulatory Affairs Support
“Post-Trial Access” (PTA) refers to the provision of a product, either investigational treatment or comparator, to clinical trial participants following trial completion.